ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Pain Medicine

Top Pain Medicine Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOSHUA REIMER MD

Pain Medicine

597

$25.2K

172
139 are 65+

13%
patients receiving schedule two controlled substances

Avg: 30%

20%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $100

QUENTIN PHUNG MD

Pain Medicine

598

$24.4K

107
48 are 65+

21%
patients receiving schedule two controlled substances

Avg: 30%

37%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $100

STEVEN CALVINO M.D.

Pain Medicine

632

$56.4K

63
41 are 65+

40%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 24%

$89
Average prescription price

Avg: $100

DANIEL KOHANE M.D.

Pain Medicine

638

$47.8K

123
71 are 65+

59%
patients receiving schedule two controlled substances

Avg: 30%

25%
patients receiving schedule three controlled substances

Avg: 18%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 24%

$75
Average prescription price

Avg: $100

SYED RAHMAN M.D.

Pain Medicine

640

$35.8K

139
102 are 65+

12%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $100

JOHN VLATTAS MD

Pain Medicine

641

$40K

103
46 are 65+

35%
patients receiving schedule two controlled substances

Avg: 30%

50%
patients receiving schedule three controlled substances

Avg: 18%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $100

SANJEEV AGARWAL M.D.

Pain Medicine

656

$22K

224
139 are 65+

11%
patients receiving schedule two controlled substances

Avg: 30%

38%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 24%

$34
Average prescription price

Avg: $100

GERMAINE ROWE MD

Pain Medicine

666

$62K

269
113 are 65+

52%
patients receiving schedule two controlled substances

Avg: 30%

13%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$93
Average prescription price

Avg: $100

CLIFFORD EVERETT M.D.

Pain Medicine

680

$20.4K

197
170 are 65+

0%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 24%

$30
Average prescription price

Avg: $100

MARIA CABODEVILLA-CONN MD

Pain Medicine

728

$65.5K

139
54 are 65+

65%
patients receiving schedule two controlled substances

Avg: 30%

31%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$90
Average prescription price

Avg: $100

DENNY BATTISTA D.O.

Pain Medicine

755

$111K

172
94 are 65+

56%
patients receiving schedule two controlled substances

Avg: 30%

13%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 24%

$148
Average prescription price

Avg: $100

VIDYASAGAR MOKUREDDY M.D.

Pain Medicine

762

$41.4K

264
123 are 65+

60%
patients receiving schedule two controlled substances

Avg: 30%

30%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $100

ELIZABETH CHANDLER MD

Pain Medicine

774

$63.4K

194
49 are 65+

71%
patients receiving schedule two controlled substances

Avg: 30%

37%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$82
Average prescription price

Avg: $100

MATTHEW KALTER M.D.

Pain Medicine

808

$90.3K

128
72 are 65+

40%
patients receiving schedule two controlled substances

Avg: 30%

22%
patients receiving schedule three controlled substances

Avg: 18%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 24%

$112
Average prescription price

Avg: $100

LEE TROSTERMAN MD

Pain Medicine

820

$93.5K

207
101 are 65+

34%
patients receiving schedule two controlled substances

Avg: 30%

14%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 24%

$114
Average prescription price

Avg: $100

ALEXANDER LEE MD

Pain Medicine

832

$61.5K

229
193 are 65+

15%
patients receiving schedule two controlled substances

Avg: 30%

21%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $100

CHARLES BUTTACI D.O.

Pain Medicine

867

$46.7K

272
200 are 65+

16%
patients receiving schedule two controlled substances

Avg: 30%

50%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $100

RENEE MELFI MD

Pain Medicine

911

$68.9K

193
157 are 65+

7%
patients receiving schedule two controlled substances

Avg: 30%

14%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$76
Average prescription price

Avg: $100

LARISA TSAUR MD

Pain Medicine

942

$111K

91
60 are 65+

19%
patients receiving schedule two controlled substances

Avg: 30%

18%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 24%

$118
Average prescription price

Avg: $100

VIJAY SIDHWANI D.O.

Pain Medicine

945

$197K

91
47 are 65+

53%
patients receiving schedule two controlled substances

Avg: 30%

15%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 24%

$208
Average prescription price

Avg: $100

SEEMA NAMBIAR MD

Pain Medicine

955

$112K

115
69 are 65+

33%
patients receiving schedule two controlled substances

Avg: 30%

16%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 24%

$118
Average prescription price

Avg: $100

TAHIR QAZI MD

Pain Medicine

974

$111K

68
38 are 65+

41%
patients receiving schedule two controlled substances

Avg: 30%

62%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$114
Average prescription price

Avg: $100

NEIL PATEL MD

Pain Medicine

993

$111K

246
150 are 65+

54%
patients receiving schedule two controlled substances

Avg: 30%

27%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$112
Average prescription price

Avg: $100

KIOOMARS MOOSAZADEH MD

Pain Medicine

1,013

$64.9K

394
323 are 65+

13%
patients receiving schedule two controlled substances

Avg: 30%

12%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $100

RAJEEV PATEL M.D.

Pain Medicine

1,032

$36.8K

398
344 are 65+

0%
patients receiving schedule two controlled substances

Avg: 30%

0%
patients receiving schedule three controlled substances

Avg: 18%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 24%

$36
Average prescription price

Avg: $100

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank